Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 43.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,727 shares of the company's stock after purchasing an additional 14,812 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.27% of Addus HomeCare worth $6,108,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Natixis raised its position in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares during the period. Parkside Financial Bank & Trust boosted its holdings in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after buying an additional 148 shares in the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in shares of Addus HomeCare during the fourth quarter valued at $86,000. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock traded up $0.48 on Thursday, reaching $112.49. The company had a trading volume of 86,999 shares, compared to its average volume of 169,136. The firm's 50-day moving average price is $105.35 and its two-hundred day moving average price is $112.60. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the prior year, the firm posted $1.21 earnings per share. The company's quarterly revenue was up 20.3% on a year-over-year basis. As a group, analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently commented on ADUS. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Macquarie upped their price target on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Stephens reissued an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of "Buy" and an average price target of $142.57.

Check Out Our Latest Report on ADUS

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares in the company, valued at approximately $896,540. The trade was a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines